Allan Sik-Yin Lau

Title: Innovations by Allan Sik-Yin Lau

Introduction

Allan Sik-Yin Lau is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-viral compounds. With a total of 2 patents to his name, Lau's work focuses on innovative solutions for treating influenza and other viral infections.

Latest Patents

Lau's latest patents include "Anti-viral carbamimidothioic acid esters" and "Anti-influenza compounds." The first patent involves carbamimidothioic acid esters that are effective in treating influenza and inhibiting viral RNA-dependent RNA polymerase. The second patent presents pyrimidinyl compounds that can be used for the treatment or prophylaxis of influenza A, specifically targeting strains such as H1N1 and H5N1. These compounds also have potential applications against various viruses, including orthomyxoviruses and paramyxoviruses.

Career Highlights

Throughout his career, Lau has worked with reputable organizations such as Versitech, Inc. and the British Columbia Cancer Agency Branch. His experience in these institutions has contributed to his expertise in the field of virology and pharmaceutical development.

Collaborations

Lau has collaborated with esteemed colleagues, including Steven J Jones and Jianghong An. These partnerships have likely enhanced his research and innovation capabilities.

Conclusion

Allan Sik-Yin Lau's contributions to the field of anti-viral research demonstrate his commitment to advancing medical science. His innovative patents reflect a dedication to finding effective treatments for viral infections.